InMed Pharmaceuticals, Inc.
Suite #310-815 W. Hastings St.
Vancouver, BC V6C 1B4
November 10, 2020
Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549-7010
InMed Pharmaceuticals Inc.
Registration Statement on Form S-1
Filed June 19, 2020, as amended
File No. 333-239319
Reference is made to the letter dated November 5, 2020, pursuant to which InMed Pharmaceuticals Inc. (the Company) requested that the effective date of the above-referenced Registration Statement be accelerated to November 9, 2020 at 5:00 p.m. (Eastern), which date was subsequently revised to November 10, 2020 (the Acceleration Request).
The Company hereby withdraws the Acceleration Request, and respectfully requests that such Registration Statement not become effective at the date and time set forth in the Acceleration Request.
|INMED PHARMACEUTICALS INC.|
|By||/s/ Eric A. Adams|
Name: Eric A. Adams
Title: President & Chief Executive Officer